Manulife (Manufacturers Life Insurance)
XFOR icon

Manulife (Manufacturers Life Insurance)’s X4 Pharmaceuticals XFOR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,720
Closed -$56.2K – 3029
2023
Q3 		$56.2K Sell
1,720
-3
-0.2% -$131 ﹤0.01% 2934
2023
Q2 		$100K Buy
+1,723
New +$88.5K ﹤0.01% 2845
2021
Q2 		– Sell
-352
Closed -$91K – 3304
2021
Q1 		$91K Buy
+352
New +$92.5K ﹤0.01% 3049
2020
Q4 		– Sell
-348
Closed -$71K – 3030
2020
Q3 		$71K Hold
348
– – ﹤0.01% 2863
2020
Q2 		$89K Buy
+348
New +$95.3K ﹤0.01% 2781
2018
Q3 		– Sell
-4
Closed -$2K – 3890
2018
Q2 		$2K Hold
4
– – ﹤0.01% 4219
2018
Q1 		$16K Buy
+4
New +$11.6K ﹤0.01% 3807

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s XFOR Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of X4 Pharmaceuticals (XFOR) in Q4 2023, closing a stake of 1,720 shares — an estimated $56.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in XFOR in Q1 2018 and held it in 7 quarters. The position peaked at $100K in Q2 2023. 93 funds tracked by Wall St. Rank hold XFOR as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining X4 Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,720 X4 Pharmaceuticals shares in Q4 2023, an estimated $56.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s X4 Pharmaceuticals position peaked at $100K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.